Share
Embed
Genetic and Molecular Epidemiology (Modern epidemiology Chap. 28)
Modern epidemiology読書会
今回の動画は「Chap.28 Genetic and Molecular Epidemiology」です.
遺伝疫学・分子疫学について勉強していきます.
バイオマーカーの妥当性・Genome-wide association studiesの基本的な部分.遺伝x遺伝,遺伝x環境要因の相互作用をどのように評価していくのか触れています.
Shuntaro Sato
January 27, 2020
Transcript
32 slides
-
Chapter 28 Genetic and Molecular Epidemiology Muin J. Khoury, Robert
Millikan, and Marta Gwinn Chuntaro (@Shuntarooo3) 1 Modern Epidemiology -
Genome? Gene? Omic 2 ਫౡ-ੁ७ࢠʢஶʣɾαΩϚΠίʢ࡞ըʣʢ2018ʣʰϚϯΨͰΘ͔Δ ήϊϜҩֶʱ༽ࣾɹ Λࢀߟʹ࡞ ճ Λ 䎠
࣏འ ڵ ↴ɾ ੨ɺ ᮊɾ ე 㥕 ࡉ๔ ֩ છ৭ମ %/" Ҩࢠ" Ҩ ࢠ # %/" N3/" λϯύΫ࣭ ήϊϜʢHFOPNFʣ ͋Δੜ͕ͭછ৭ମதʹ͋Δ ͯ͢ͷ%/"ྻใͷ͜ͱ ʢશҨใʣ ҨࢠʢHFOFʣ %/"ͷҰ෦Ͱɼʮ͜ͷྻʹ͠ ͕ͨͬͯλϯύΫ࣭Λ࡞Εʯͱ໋ ྩ͍ͯ͠Δ෦ͷ͜ͱ (FOPNJDT 1SPUFPNJDT w 5SBOTDSJQUPNJDT w .FUBCPOPNJDT w /VUSJHFOPNJDT w 1IBSNBDPHFOPNJDT w 5PYJDPHFOPNJDT 0NJD ͞·͟·ͳཏతੜମࢠΛ ·ͱΊͨࣝɾू߹ͷ͜ͱ -
Genetic and Molecular Epidemiology 3 &YQPTVSFT 4VTDFQUJCJMJUZ 0VUDPNFT #JPMPHJDNBSLFST w
ײછӸֶɿ߅ମՁ w ৺݂࣬ױӸֶɿ݂தࢷ࣭ w ڥӸֶɿಟૉͷ݂தೱ .PMFDVMBSFQJEFNJPMPHZʢࢠӸֶʣ (FOFUJDFQJEFNJPMPHZʢҨӸֶʣ (FOFUJD GBDUPST 0VUDPNFT Wellcome Trust Case Control Consortium. (2007). Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature, 447(7145), 661. (FOF %JTFBTF %JTFBTF (FOF (FOF º (FOF &OWJSPONFOU º %JTFBTF -
Overview 4 (FOF %JTFBTF %JTFBTF (FOF (FOF º (FOF &OWJSPONFOU
º %JTFBTF "OBMZUJDBOENFUIPEPMPHJDBMJTTVFT &YBNQMF w େ͕Μ w ԌੑେԌ %POPUDPWFSUSBEJUJPOBMHFOFUJDBOBMZTFT w Ոܥੳ w ࿈ղੳ w Ϛοϐϯά -
MULTIDISCIPLINARY APPROACHES TO THE EVALUATION OF BIOMARKERS (p. 566) 5
"OBMZUJDWBMJEJUZʢੳతଥੑʣ ͲͷΑ͏ͳόΠΦϚʔΧʔͰ͋ͬͯଥੑͷධՁඞཁ $MJOJDBMWBMJEJUZʢྟচతଥੑʣ $MJOJDBMVUJMJUZʢྟচత༗༻ੑʣ -
ANALYTIC VALIDITY (p. 566) 6 "OBMZUJDWBMJEJUZ ʢੳతଥੑʣ "DDVSBDZ ʢਖ਼֬ੑʣ
Biomarker Test Present Absent + A B - C D = A A + C = D B + D "OBMZUJDTFOTJUJWJUZ ʢײʣ "OBMZUJDTQFDJpDJUZ ʢಛҟʣ ੳతଥੑɼαϯϓϧͷछྨɼॲཧɼอଘ͓ΑͼΞοηΠͷଥੑʹґଘ͢Δ -
CLINICAL VALIDITY (p. 566) 7 ੳతଥੑΛ্ཱ֬ͨ͠Ͱɼ ࣍ྟচతଥੑΛྟচ͓ΑͼӸֶݚڀͰධՁ͢Δඞཁ͕͋Δ Clinical Outcome Biomarker
Present Absent + A B - C D = A A + C = D B + D $MJOJDBMTFOTJUJWJUZ ʢײʣ $MJOJDBMTQFDJpDJUZ ʢಛҟʣ = A A + B = D C + D 1PTJUJWFQSFEJDUJWFWBMVF ʢཅੑదதʣ /FHBUJWFQSFEJDUJWFWBMVF ʢӄੑదதʣ ࣬ױ͋Γͷݸମʹରͯ͠ ʢਖ਼͘͠ʣཅੑͱஅ͢Δ֬ ࣬ױͳ͠ͷݸମʹରͯ͠ ʢਖ਼͘͠ʣӄੑͱஅ͢Δ֬ ཅੑͱஅ͞Εͨݸମʹ͓͍ͯ ਅʹ࣬ױ͕ଘࡏ͢Δ֬ ӄੑͱஅ͞Εͨݸମʹ͓͍ͯ ਅʹ࣬ױ͕ଘࡏ͠ͳ͍֬ -
CLINICAL UTILITY (p. 567) 8 ྟচత༗༻ੑͱɼݕࠪʹΑΓΞτΧϜ͕ྑ͘ͳΔ֬Λࣔ͢ #VSLFFUBM Outcome Intervention Sick
Not 1 A B 2 C D όΠΦϚʔΧʔ͕ཅੑͷݸମͷྟচత༗༻ੑධՁ ͜ͷදɼόΠΦϚʔΧʔཅੑͷݸମʹରͯ͠ɼ ϥϯμϜʹ࣏ྍΛׂΓͯɼ࣏ྍͷޮՌΛධՁ͍ͯ͠Δ 3$5ˠ όΠΦϚʔΧʔͷྟচత༗༻ੑͷධՁʹͳ͍ͬͯΔʁ ? -
ETHICAL, LEGAL, AND SOCIAL ISSUES (p. 567) 9 όΠΦϚʔΧʔʢಛʹҨใʣΛ༻͢Δݚڀɼͨ͘͞Μͷ FUIJDBMʢྙཧతʣ
MFHBMʢ๏తʣ TPDJBMʢࣾձతʣͷJTTVFʢ՝ʣ E L S I w ΠϯϑΥʔϜυɾίϯηϯτ w ඃݧऀͷืू w ݚڀ݁Ռʹؔ͢Δใͷ։ࣔ w ݸਓूஂʹର͢ΔࠩผͷՄೳੑ -
CONVENTIONAL EPIDEMIOLOGIC STUDIES (p. 568) 10 w $BTFDPOUSPMTUVEJFT w $PIPSUTUVEJFT
w $SPTTTFDUJPOBMTUVEJFT -
AlleleɾGenotype 11 છ৭ମ A - T T - A G
- C C - G T - A ߏΛ֦େ Ԙجྻ %/" ˢ૬ิྻ A A A A A A A a ༝དྷ ༝དྷ w ԘجͷόϦΤʔγϣϯΛΞϦϧʢBMMFMFʣ ͱ͍͏ w ΞϦϧͷΈ߹Θͤ ʮ""PS"BPSBBʯΛδΣϊλΠϓ ʢHFOPUZQFʣͱ͍͏ -
SNV (Single Nucleotide Variant) 12 *% MPDVT MPDVT MPDVT MPDVT
MPDVT "" "" "" "" "" "" "" "( "" "" "" "" (( "" "" ͞ͷԘجΛ࠲ҐʢMPDVTʣͱ͢Δ େಉҰ w ͱ͖Ͳ͖ҟͳΔΞϦϧΛؚΉมҟʢόϦΞϯτɼWBSJBOUʣ͕͋Δ w ԘجͷόϦΞϯτ4/7ʢ4JOHMF/VDMFPUJEF7BSJBOUʣ -
SNPɾMAF 13 δΣϊλΠϓ "" "B BB 5PUBM /
͋Δूஂʢ໊ʣͷ͋Δ4/7Λߟ͑Δ ΞϦϧ " B 5PUBM / ස º º ϚΠφʔΞϦϧස ʢ."'NJOPSBMMFMF GSFRVFODZʣ සͷগͳ͍ΞϦϧ 4/1ʢҰԘجଟܕʣ."'㱢ͷ4/7ͷ͜ͱ -
CASE-CONTROL STUDIES (1) (p. 568) 14 ҨࢠϚʔΧʔײडੑҼࢠͱͯ҆͠ఆ͍ͯ͠ΔͨΊɼ DBTFDPOUSPMTUVEJFTʹద͍ͯ͠Δ 3FDBMMCJBTগͳ͍
4VTDFQUJCJMJUZʢײडੑʣͱʁ Ҩੑ࣬ױ ୯ҰҨࢠ࣬ױ ଟҨੑ࣬ױʢ͋Γ;Εͨ࣬ױɼෳࡶ࣬ױɼDPNNPOEJTFBTFʣ ͭͷ࠲ҐʹΑܾͬͯఆతʹӨڹ͞ΕΔ খ͍͞د༩Λͬͨଟ͘ͷҨతཁҼʹΑͬͯදݱܕ͕ܾఆ͞ΕΔ ײडੑҼࢠʢTVTDFQUJCJMJUZGBDUPSʣ w $POUSPM܈ʹରͯ͠$BTF܈ͰόϦΞϯτͷස͕༗ҙʹߴ͍͕ɼ Ұൠͷ݈ৗਓͦ͠͠ͷόϦΞϯτΛ༗͢Δ w $BTF܈Ͱ͋ͬͯόϦΞϯτ͕ͳ͍ݸମ͋ΓಘΔ -
CASE-CONTROL STUDIES (2) (p. 568) 15 ͭͷόϦΞϯτͱ࣬ױͱͷؔ࿈͚ͩͰͳ͘ɼ ଞͷόϦΞϯτཁҼͱڞʹ࣬ױͱͷؔ࿈Λ୳ࡧͰ͖Δ w
(FOFHFOFJOUFSBDUJPO w (FOFFOWJSPONFOUJOUFSBDUJPO ·ΕͳΤϯυϙΠϯτʢ3BSFEJTFBTFʣʹద͍ͯ͠Δ -
CASE-CONTROL STUDIES (3) (p. 568) 16 0VUDPNF : $PWBSJBUF &
4/1 ( 4/1 ( ʜ 4/1K ( w ήϊϜϫΠυؔ࿈ղੳʢ(8"4HFOPNFXJEFBTTPDJBUJPOTUVEZʣ w σβΠϯέʔεɾίϯτϩʔϧݚڀ w ֤4/1ͱΞτΧϜʢܗ࣭ʣͱͷؔ࿈Λݕ౼͢ΔϞσϧ w 4/1ͷ͚ͩݕఆΛ܁Γฦ͢ 4/1ेສʙઍສ -
COHORT STUDIES (p. 568) 17 ͋Γ;Εͨ࣬ױͱؔ࿈͢ΔҨࢠΛൃݟ͢ΔͨΊʹཱͭ w ॎஅతͳඇৗʹେنͳूஂ w όΠΦόϯΫͷཱ֬
Study Sample size Population Study Objectives Decode Genetics > 100,000 Iceland • ͋Γ;Εͨ࣬ױͷݪҼͱͳΔҨࢠͷಉఆ • ৽ༀͷ։ൃ UK Biobank 500,000 Population sample of persons aged 45-69 y • Ҩࢠɼڥɼੜ׆ελΠϧͷׂ • Medical recordͱϦϯΫ CartaGene (Quebec) > 60,000 Population sample of persons aged 25-74 y • Ҩࢠɼڥɼੜ׆ελΠϧɼ Medical recordͱϦϯΫ Estonia Genome Project > 1,000,000 Estonian population • ͋Γ;Εͨ࣬ױͷݪҼͱͳΔҨࢠͷಉఆ • Medical recordͱϦϯΫ GenomeEUTwin ʙ800,000 twin pairs Twin cohorts from 7 European countries + Australia • Ҩࢠɼڥɼੜ׆ελΠϧͷׂ ॊೈʹෳࡶͳϝΧχζϜɾԾઆ ʹରԠͰ͖Δ -
METHODOLOGIC ISSUES CONFOUNDING (p. 570) 19 ڵຯͷ͋ΔόϦΞϯτ ࣬ױ 3BDFFUIOJDJUZ ʢਓछຽੑʣ
ަབྷҼࢠ ަབྷҼࢠͷௐํ๏ -PHJTUJDSFHSFTTJPONPEFM :ˡ4/1 ڞมྔɹ㱺ɹ4/1ʹ͍ͭͯͷݕఆ :ˡ4/1 ڞมྔɹ㱺ɹ4/1ʹ͍ͭͯͷݕఆɹŋŋŋҎԼಉ༷ (FOPUZQFDPEJOH $PWBSJBUFT XIFSF Gi 2 {0, 1, 2} Ei logit[Pr(Yi = 1)] = logit[⇡i( 0, e, g)] = 0 + eEi + gGi ⇡i = Pr(Yi = 1) -
GENOTYPE AND EXPOSURE MISCLASSIFICATION (1) (p. 570) 20 /POEJ⒎FSFOUJBMNJTDMBTTJpDBUJPOʢඇࠩҟޡྨʣ όΠΦϚʔΧʔʢʣͱΞτΧϜͱͷؔ࿈Λرऍ͢Δ
ଞͷมͱແؔͳޡྨʢؔ͢Δͷࠩҟޡྨʣ$IBQ /VMMํಇ͘ ਖ਼֬ͳྨ ඇࠩҟྨΛͨ͠߹ (-)ͷ20%→(+) (-)ͷ20%→(+) (+)ͷ20%→(-) Biomarker Biomarker Biomarker Clinical outcome + - + - + - Present 250 450 360 360 410 290 Absent 100 900 720 280 740 260 Odds Ratio 5.0 2.4 2.0 Kenneth J. Rothman, ༁ʢຊా߶, ྛ༤Ұ, & ࠤ౻تʣ. ϩεϚϯͷӸֶ ୈ2൛, 2013.ͷද7-6Λࢀߟʹ࡞ -
GENOTYPE AND EXPOSURE MISCLASSIFICATION (2) (p. 570) 21 w ࿈ෆฏߧঢ়ଶ͕ڧ͍όϦΞϯτɼ࣬ױͱͷؔ࿈͕ڧ͘ͳΔ
w ੈ͕ܦͭʹͭΕɼ࿈ෆฏߧঢ়ଶ͕ऑ͘ͳΓɼ࣬ױͱͷؔ࿈رऍ͞ΕΔ ୈੈ Oੈ ࣬ױͱؔ࿈ͷ͋ΔόϦΞϯτʢ"ʣ όϦΞϯτʢ"ʣͱڑ͕ۙ͘ɼOੈܦͬͯ࿈ฏߧঢ়ଶʹͳ͍ w Ҩࢠɼݮ྾ͷࡍʹΈ͑Λى͜͢ w ಉ͡છ৭ମͰɼڑ͕͍ۙҨࢠ࠲όϦΞϯτʢ"ʣͱ ηοτʹͳͬͯΘΔ w ͭͷҟͳΔόϦΞϯτͱͷؔ࿈ͷఔΛ ࿈ෆฏߧʢ-JOLBHFEFTFRVJMJCSJVNʣͱ͍͏ ʢ૬ؔΈ͍ͨͳͷʣ w ؔ࿈͕ڧ͍ͱ͖ɼ࿈ෆฏߧڧ͍ ඇࠩҟޡྨʹΑΔ -
GENE-ENVIRONMENT INTERACTION (1) (p. 570) 22 (FOFUJDGBDUPS ( EJTFBTF &OWJSPONFOUBMGBDUPS
& PS&YQPTVSF "MMIVNBOEJTFBTFҨͱڥཁҼͱͷ૬ޓ࡞༻͕ݪҼͰ͋Δ º .BSHJOBMʹධՁ͢Δͱɼ૬ޓ࡞༻͕ϚεΫ͞ΕΔ (FOFUJDGBDUPS ( EJTFBTF EJTFBTF &OWJSPONFOUBMGBDUPS & PS&YQPTVSF ҨཁҼʹΑΔϦεΫ ڥཁҼʹΑΔϦεΫ -
GENE-ENVIRONMENT INTERACTION(2) (p. 570) 23 Exposure Geno- type Cases Controls
Contrast Odds ratio Main information - - A00 B00 A OR00 = 1.0 (Reference) Common reference - + A01 B01 B B vs. A OR01 = A01B00 /(A00B01) Genotype alone vs. none + - A10 B10 C C vs. A OR10 = A10B00 /(A00B10) Environmental factor alone vs. none + + A11 B11 D D vs. A OR11 = A11B00 /(A00B11) Join genotype and environmental factor vs. none Multiplicative interaction D/(B * C) Deviation from multiplicative modelʢ๏Ϟσϧʣof interaction Additive interaction D - (B + C - 1) Deviation from additive modelʢՃ๏Ϟσϧʣof interaction (FOF&OWJSPONFOU*OUFSBDUJPO"OBMZTJTJOB$BTF$POUSPM4UVEZ Ҩڥަޓ࡞༻ͷղੳ͜ͷද͕͓͢͢Ί w ใͷϩε͕ͳ͍ w ަޓ࡞༻ͷد༩͕͔Δ w ૉͷใ͕͋Δ͔Βɼ৴པ۠ؒͷܭࢉՄೳ -
EMERGING ANALYTIC COMPLEXITY(1) (p. 571) 24 ِཅੑͷ੍ޚʢଟॏੑͷʣ w (8"4Ͱଟ͘ͷ4/7ʹ͍ͭͯݕఆΛ͓͜ͳ͏ˠଟॏੑͷ w
#POGFSSPOJิਖ਼Ͱɼ༗ҙਫ४º w ϕΠζతख๏։ൃ͞Ε͍ͯΔ খඪຊߴ࣍ݩσʔλ w QO w มʹൺֱͯ͠αϯϓϧαΠζ͕খ͍͞ w ݟ্͔͚શʹ༧ଌͰ͖ΔϞσϧʢཁҼͷΈ߹Θͤʣ͕େʹಘΒΕͯ͠ ·͏ w ࣍ݩͷढ͍ w Έ߹ΘͤʢHFOFHFOF HFOFFOWJSPONFOUBMJOUFSBDUJPOʣ͕രൃతʹ૿ ͑Δ -
EMERGING ANALYTIC COMPLEXITY(2) (p. 571) 25 /PWFMBOBMZUJDTUSBUFHJFT w ֊ܕճؼੳ w
ϕΠζਪఆ w $PNCJOBUPSJBMQBSUJUJPOJOHNFUIPE $1. w .VMUJGBDUPSEJNFOTJPOBMJUZSFEVDUJPO .%3 NFUIPE Flanders, W. D., & Khoury, M. J. (1996). Analysis of case-parental control studies: method for the study of associations between disease and genetic markers. American Journal of Epidemiology, 144(7), 696–703. -
CASE-ONLY STUDIES (p. 573) 27 $BTFPOMZEFTJHOʹ͍ͭͯɼ%S,*%ઌੜͷαΠτΛࢀߟʹͤͯ͞ ͍͖ͨͩ·ͨ͠ $BTF0OMZ%FTJHOʹ͍ͭͯʦҨӸֶʧʛ(FOF&OWJSPONFOUBM*OUFSBDUJPO ʢIUUQTXXXESLJEOFUDBTFPOMZHFOFQJʣ w
$BTFͷΈΛରʹݚڀΛ͓͜ͳ͏ํ๏ w (FOFHFOF (FOFFOWJSPONFOUBMJOUFSBDUJPOΛධՁͰ͖Δ Exposure Genotype Cases - - A00 - + A01 + - A10 + + A11 Case-only odds ratio = (A11A00)/(A10A01) ΑΓେ͖͍ͱ͖ɼ ަޓ࡞༻ͷՄೳੑ͕ࣔࠦ͞ΕΔ w .BJOF⒎FDUʢҨࢠڥ͕ΞτΧϜʹ༩͑ΔӨڹʣΘ͔Βͳ͍ w ҨࢠͱڥཁҼ͕ಠཱ͍ͯ͠Δඞཁ͕͋Δ -
CASE-PARENT STUDIES (p. 575) 28 $BTF $POUSPM w ࣬ױΛൃͨ͠$BTFͷΛ$POUSPMͱ͢ΔσβΠϯ w
ਓछɼຽɼҨతഎܠͱ͍ͬͨަབྷҼࢠΛऔΓআ͘͜ͱ͕Ͱ͖Δ w $BTFDPIPSUσβΠϯͷྨܕ Genotype + - Case A B Control C D -
EXAMPLE 1: COLORECTAL CANCER (p. 575) 29 ߴසͷͷઁऔ େ͕Μ )FUFSPDZMJDBNJOFT
)$"T ൃ͕Μੑ࣭ ैདྷͷӸֶ Ոྺ հೖʹΑΓϦεΫԼ Ҩࢠมҟ ΑΓऑ͍Ҩࢠมҟ ڥཁҼ º ҨӸֶɾࢠӸֶ Ҩࢠ εΫϦʔχϯά ศதͷಛҟతͳ Ҩࢠมҟ ૣظൃݟ ҨࢠϓϩϑΝΠϦϯά w αϒλΠϓʹྨ w దͳ࣏ྍΛબ -
EXAMPLE 2: INFLAMMATORY BOWEL DISEASE (1) (p. 577) 30 w
Ԍੑ࣬ױͱͯ͠Ϋϩʔϯපͱ௵ᙾੑେԌΛѻ͏ w (8"4͕ޭΛऩΊͨ࣬ױ w (8"4ͷ݁Ռɼൃػংͷ࠶ߟΛଅͨ͠ w ৫ଛইΛҾ͖ى͜͢৽ͨͳ࣭ͷൃݟ w Ϋϩʔϯපͷ࣏ྍ๏ͱͯ͠ *-ʹର͢ΔϞϊΫϩφʔϧ߅ମΛ༻ͨ͠ྟচࢼݧͷ࣮ࢪΛଅͨ͠ ؔ࿈όϦΞϯτͷ ࣬ױ 2007ΑΓલʹಉఆ͞Εͨ όϦΞϯτ 2007͔Β2013த·Ͱʹಉఆ ͞ΕͨόϦΞϯτ Ϋϩʔϯප 3 (NOD2, IBD5, IL23R) 140 ௵ᙾੑେԌ 1 (IL23R) 133 ଟൃੑߗԽ 0 52 ݪൃੑोੑ؊ߗม 0 28 ؔઅϦϚν 2 (PAD14, CTLA4) 30 શੑΤϦςϚτʔσε 2 (PTPN22, IR5) 31 1ܕප 3 (INS, PTPN22, IRF5) 40 ʹ࠷ॳͷ(8"4͕ൃද͞Εͨ Tom Strachan et al., ༁ʢੁ७, & ౢٛޫʣ. Genetics and Genomics in MedicineʢήϊϜҩֶʣ, 2016.ͷද8.10Λࢀߟʹ࡞ -
ࢀߟจݙ ,FOOFUI+3PUINBO ༁ʢຊా߶ ྛ༤Ұ ࠤ౻تʣϩεϚϯͷӸֶୈ൛ ࣰݪग़ ൛৽ࣾ 5PN4USBDIBOFUBM
༁ʢੁ७ ౢٛޫʣήϊϜҩֶ ϝσΟΧϧɾαΠΤϯεɾ Πϯλʔφγϣφϧ ਫౡੁ७ࢠʢஶʣɾαΩϚΠίʢ࡞ըʣϚϯΨͰΘ͔ΔήϊϜҩֶ ༽ࣾ "OESFB4'PVMLFT ༁ʢࢁؽʣ࣮ફͰΘ͔Δʂ3ʹΑΔ౷ܭҨֶ ؙળग़൛ ా ২༏ήϊϜσʔλղੳ ڞཱग़൛ ాٶݩ ২༏ খཧήϊϜҩֶͷͨΊͷҨ౷ܭֶ ڞཱग़൛ 31